India’s pharmaceutical sectorvalued at over $50 billion and often dubbed “the pharmacy of the world”- has consistently expanded its global footprint. With rising demand for affordable generics, complex APIs, and vaccines, Indian pharma firms are doubling down on new markets. In recent years, Southeast Asia and the MENA (Middle East and North Africa) region have emerged as the new epicentres of India’s export ambitions.